J2KBIO Co., Ltd. (KOSDAQ:420570)
South Korea
· Delayed Price · Currency is KRW
12,030
+720 (6.37%)
At close: Mar 26, 2025, 3:30 PM KST
J2KBIO Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Apr '25 Apr 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Market Capitalization | 73,652 | 51,996 | - | - | - | - |
Enterprise Value | 62,686 | 41,858 | - | - | - | - |
Last Close Price | 12890.00 | 9100.00 | - | - | - | - |
PS Ratio | 2.15 | 1.57 | - | - | - | - |
PB Ratio | 2.38 | 1.66 | - | - | - | - |
P/TBV Ratio | 1.68 | 1.68 | - | - | - | - |
P/FCF Ratio | 3151.05 | 2224.56 | - | - | - | - |
P/OCF Ratio | 7.51 | 7.51 | - | - | - | - |
EV/Sales Ratio | 1.89 | 1.26 | - | - | - | - |
EV/EBITDA Ratio | 13.21 | 8.82 | - | - | - | - |
EV/EBIT Ratio | 17.29 | 11.54 | - | - | - | - |
EV/FCF Ratio | 2681.91 | 1790.83 | - | - | - | - |
Debt / Equity Ratio | 0.07 | 0.07 | 0.07 | 0.42 | 0.59 | 0.70 |
Debt / EBITDA Ratio | 0.44 | 0.44 | 0.20 | 1.59 | 2.20 | 3.45 |
Debt / FCF Ratio | 89.34 | 89.34 | 0.65 | 3.46 | 4.36 | - |
Asset Turnover | 1.14 | 1.14 | 1.44 | 0.95 | 0.97 | - |
Inventory Turnover | 7.27 | 7.27 | 6.47 | 5.03 | 7.59 | - |
Quick Ratio | 6.64 | 6.64 | 2.90 | 2.52 | 2.37 | 2.51 |
Current Ratio | 7.88 | 7.88 | 3.78 | 3.26 | 2.87 | 3.02 |
Return on Equity (ROE) | -6.80% | -6.80% | 33.43% | 20.83% | 20.06% | - |
Return on Assets (ROA) | 7.82% | 7.82% | 17.69% | 8.60% | 7.97% | - |
Return on Capital (ROIC) | 8.63% | 8.63% | 20.29% | 9.79% | 8.85% | - |
Return on Capital Employed (ROCE) | 10.80% | 10.80% | 30.60% | 16.20% | 14.30% | 10.10% |
Earnings Yield | -2.24% | -3.18% | - | - | - | - |
FCF Yield | 0.03% | 0.04% | - | - | - | - |
Payout Ratio | 0.00% | - | 4.96% | - | - | - |
Buyback Yield / Dilution | -11.59% | -11.59% | 1.76% | -8051.19% | - | - |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.